Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Wyeth narrowing focus of research to 6 areas, shifting women's health research to new diseases
Yahoo/AP
Thursday, October 30, 2008 - 10:49am
tags:
Biotech funding crisis poses risks to innovation
Guardian, UK
Wednesday, October 29, 2008 - 5:24pm
tags:
Biogen Says Brain Illness Found in Tysabri Patient
Bloomberg
Wednesday, October 29, 2008 - 5:22pm
tags:
Allergan reduces expectations in 2008, and says economic woes will cut 2009 profit growth
Yahoo/AP
Wednesday, October 29, 2008 - 5:22pm
tags:
FDA Objected to Regulation Moves, Rep. Waxman Says
WSJ Online
Wednesday, October 29, 2008 - 5:17pm
tags:
Allergan and Spectrum in bladder cancer drug pact
Yahoo/AP
Wednesday, October 29, 2008 - 4:35pm
tags:
JP Morgan Analyst: Johnson & Johnson Not Worth the Sum of Its Parts
Seeking Alpha
Wednesday, October 29, 2008 - 4:30pm
tags:
Credit Crisis Hits Drugmakers
Motley Fool
Wednesday, October 29, 2008 - 4:28pm
tags:
Improving the Use of Drugs Through Genes
Businessweek
Wednesday, October 29, 2008 - 10:37am
tags:
More big changes for Wyeth
Fierce Pharma
Wednesday, October 29, 2008 - 10:36am
tags:
Grim Outlook for Big Pharma on Capitol Hill
WSJ Online
Wednesday, October 29, 2008 - 10:32am
tags:
Report: US drug sales growth heads toward new low
Yahoo/AP
Wednesday, October 29, 2008 - 10:31am
tags:
Pozen's 3Q loss bigger than expected
Bizjournals.com
Wednesday, October 29, 2008 - 10:18am
tags:
Sepracor Putting Cash to Work
Yahoo/Zacks.com
Wednesday, October 29, 2008 - 10:18am
tags:
Cephalon reports profit spike on charges, raises outlook
Marketwatch
Wednesday, October 29, 2008 - 9:35am
tags:
Pfizer Needs Isis More Than Isis Needs Pfizer
Seeking Alpha
Wednesday, October 29, 2008 - 9:33am
tags:
Novartis: Rasilez HCT approved to treat high blood pressure
Marketwatch
Wednesday, October 29, 2008 - 9:32am
tags:
Study: Schering-Plough anti-anesthesia drug brings much faster recovery than the standard one
Yahoo/AP
Wednesday, October 29, 2008 - 9:31am
tags:
J&J's Prevention Cure
Forbes
Wednesday, October 29, 2008 - 9:26am
tags:
Alcon Takes A Poke In The Eye
Investopedia
Wednesday, October 29, 2008 - 9:25am
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.